HROW Q1 2021 Earnings — Harrow Health, Inc. Revenue & Financial Results | Market Cap Arena

HROWHarrow Health, Inc.

$1B

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$15M+30.7% YoY

Gross Profit

$12M75.6% margin

Operating Income

$3M18.9% margin

Net Income

$217,0001.4% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

+5.8%

Cash Flow

Operating Cash Flow

$3M

Free Cash Flow

$3M

Stock-Based Comp.

$855,000

Balance Sheet

Total Assets

$56M

Total Liabilities

$28M

Stockholders' Equity

$28M

Cash & Equivalents

$6M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$15M	$12M	+30.7%
Gross Profit	$12M	$8M	+42.5%
Operating Income	$3M	-$628,000	+564.5%
Net Income	$217,000	-$13M	+101.7%

Revenue Segments

Other Revenues

$495,000100%